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DURATION 
 
Reading Time: 10 minutes 
Writing Time: 180 minutes 
 
INSTRUCTIONS TO CANDIDATES 
 
This examination has 2 (A and B) Sections: 
Section A contains Forty (40) Multiple Choice Questions.  Answer all questions on the College supplied Multiple 
Choice Answer Sheet.  Total marks allocated: Twenty (20). 
Suggested time allocation: One (1) hour. 
Section B contains Ten (10) Extended-Answer Questions.  Answer any Eight (8) questions only in the 20-page 
Booklet provided.  Total marks allocated: Eighty (80). 
Suggested time allocation: Two (2) hours. 
 
EXAM CONDITIONS 
You may begin writing from the commencement of the examination session.  The reading time indicated above is 
provided as a guide only. 
This is a CLOSED BOOK examination 
No calculators are permitted 
No handwritten notes are permitted 
No dictionaries are permitted 
 
ADDITIONAL AUTHORISED MATERIALS EXAMINATION MATERIALS TO BE SUPPLIED 
 




1 x 20 Page Book 
1 x Scrap Paper 
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Total No. of Marks for this Section: 80 
Please answer this section in the 20-page Answer Booklet provided.  Ensure that your name and 
student number have been written on the front page of the answer booklet. 
Answer any EIGHT (8) questions. 
Marks for each question are indicated.  Suggested time allocation: 120 mins 
 
Question 1 
Mr AH walks into an enclosed area which is being fumigated with an organophosphate 
insecticide. 
a. Describe SIX (6) symptoms Mr. AH is likely to experience.  Include in your answer, 
explain how they occur. 
 (6 marks) 
b. How could this poisoning be treated? 









a. Describe the therapeutic use(s) and mechanisms of action of the active 
ingredients in Vytorin. 
  (8 marks) 
b. What are the consequences if a patient is not compliant with taking this 
medication? 
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Question 3 (multiple topics) 
a. Explain why the activity for a local anaesthetic could be reduced when it is injected into 
areas with inflammation? 
 (5 marks) 
b. Triple therapy (omeprazole, amoxicillin and clarithromycin) is often required for the 
treatment of peptic ulcers.  Describe the mechanism of action of omeprazole and 
explain when this therapy is necessary. 






Question 4 (multiple topics) 
a. Many drugs are extensively bound to plasma proteins.  Discuss the significance of this 
for the drug’s effect, especially in the presence of a competitor, and its elimination.  
 (4 marks) 
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a. What disorder is Mrs RS likely to be suffering from? (1 mark) 
b. Describe the mechanism(s) of action of the active ingredient in Cordarone X and 
explain how it benefits Mrs RS. 
  (6 marks) 
c. A loading dose of this agent is needed when commencing the treatment.  Explain 
what is meant by “loading dose” and the reason for this requirement. 




Question 6 (multiple topics) 
a. Describe and differentiate the mechanism(s) of action and clinical uses of amlodipine 
and verapamil. 
  (4 marks) 
b. Describe the mechanisms of action of glyceryl trinitrate (GTN) in relieving the symptoms 
of angina. 
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a. Describe the mechanisms of action of the active ingredients in Asasantin. 
  (7 marks) 
b. What are the consequences if a patient is not compliant with taking this 
medication? 







Question 8 (multiple topics) 
a. Describe and differentiate the mechanisms of action of amiloride and spironolactone. 
  (4 marks) 
b. Describe the mechanism of action of digoxin and the mechanism(s) of drug-drug 
interactions when it is used with furosemide for the treatment of congestive heart 
failure. 
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a. Describe the mechanism of action of heparin and comment on the differences in 
pharmacology between unfractionated and low molecular weight heparin (LMWH). 
  (4 marks) 
b. Describe the mechanism of action of warfarin and explain why there is a requirement 
for heparin co-administration when commencing warfarin therapy. 






a. Describe how trandolapril and telmisartan act to lower blood pressure. 
  (5 marks) 
b. What problem can arise when trandolapril is used together with naproxen (a non-
steroidal anti-inflammatory agent).  Explain how that occurs. 







End of Sections B 
 
End of Exam Paper 
 
 
